Myocardial Effects of NIV in OHS Patients
Long-term Myocardial Effects of Noninvasive Ventilation in Patients With Obesity Hypoventilation Syndrome
1 other identifier
interventional
13
1 country
1
Brief Summary
Chronic effects of noninvasive ventilation on myocardial function in patients with obesity hypoventilation syndrome (OHS) are scarcely understood. The aim of the present study was to evaluate the long-term effects of volume-targeted bilevel-positive airway pressure ventilation (BiPAP) on cardiac parameters and myocardial biomarkers in patients with OHS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2020
CompletedFirst Submitted
Initial submission to the registry
June 20, 2024
CompletedFirst Posted
Study publicly available on registry
July 3, 2024
CompletedJuly 3, 2024
June 1, 2024
3.7 years
June 20, 2024
June 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Impedance cardiography measured cardiac output
Impedance cardiography measured cardiac output before and after effective treatment of respiratory failure
12 months
Secondary Outcomes (1)
Impedance cardiography measured stroke volume
12 months
Study Arms (1)
Obesity hypoventilation syndrome patients treated with BPAP (NIV) therapy
EXPERIMENTALClinically stable patients with OHS and severe hypercapnia during the daytime, referred to the tertiary clinic for the initiation of long-term NIV to alleviate chronic respiratory failure were consecutively enrolled to the study
Interventions
he aim of the present study was to evaluate the long-term effects of volume-targeted bilevel-positive airway pressure ventilation (BiPAP) on cardiac parameters and myocardial biomarkers in patients with OHS
Eligibility Criteria
You may qualify if:
- \- Clinically stable patients with OHS and chronic severe hypercapnia
You may not qualify if:
- inability to provide written informed consent
- neuromuscular diseases
- chest wall diseases
- metabolic diseases
- acute respiratory tract infection
- chronic obstructive pulmonary disease (COPD)
- systolic LV failure as evidenced by LV ejection fraction\<45% on echocardiography
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of respiratory medicine and tuberculosis, Pavol Jozef Safarik University, Medical Faculty and L. Pasteur University Hospital In Kosice
Košice, 04190, Slovakia
Related Publications (1)
Pobeha P, Paranicova I, Trojova I, Tkacova R, Joppa P. Acute hemodynamic effects of non-invasive ventilation in patients with obesity hypoventilation syndrome. Bratisl Lek Listy. 2021;122(4):248-250. doi: 10.4149/BLL_2021_040.
PMID: 33729816BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Pavol Pobeha, MD, PhD (Principal investigator)
Study Record Dates
First Submitted
June 20, 2024
First Posted
July 3, 2024
Study Start
March 1, 2016
Primary Completion
November 15, 2019
Study Completion
January 15, 2020
Last Updated
July 3, 2024
Record last verified: 2024-06